
We’re excited to share more about Indonesia’s NHI system! It’s incredible to see how they implemented universal healthcare and overcame unique challenges.
These insights are based on a recent interview by Alec Hogg and Ali Ghufron Mukti but through the lens of health economics and outcomes research, and access to medicines.
Of course, no system is perfect, and Indonesia’s NHI journey reminds us of the importance of constant vigilance to address challenges like funding and corruption issues.
Thank you for sharing these important lessons!
Recent Posts
Disrupting Prescription Drug Pricing: Mark Cuban’s Cost-Plus Vision
Exposing Prescription Drug Pricing Flaws
Prescription drug pricing in the US is riddled with inefficiencies, as revealed in this JAMA interview published online on Febru...
Pharmaceutical Tender Investigation Sparks Regulatory Scrutiny in South Africa
Pharmaceutical Tender Investigation Targets Ascendis, Pharma Q, and Sonke
The Competition Commission of South Africa has launched a pharmaceutical tender investigation into manufacturers Ascendis, Pharma Q, and...
Strategic Vision and Infarmed 2026 Priorities for Regulatory Reform
Infarmed 2026 Priorities Take Shape in Leadership Summit
Infarmed 2026 priorities crystallized during the Executive Board's February 11, 2026, session with unit directors, led by President Rui Santos Ivo, Vice-President Raque...